Source comparison
CJC-1295 vs Sermorelin
Sermorelin is a 29-amino acid peptide corresponding to the first 29 amino acids of natural GHRH. Unlike CJC-1295, it lacks the modifications that provide DPP-IV resistance. The result? Sermorelin has an even shorter half-life than Mod GRF 1-29, approximately 1
This comparison does not assign a generated winner or score.
- Sermorelin is a 29-amino acid peptide corresponding to the first 29 amino acids of natural GHRH. Unlike CJC-1295, it lacks the modifications that provide DPP-IV resistance.
- The result? Sermorelin has an even shorter half-life than Mod GRF 1-29, approximately 10-20 minutes. This requires very frequent dosing and produces smaller GH pulses.
- Sermorelin's advantage is its longer history of clinical use and FDA approval for diagnosing growth hormone deficiency. Some researchers prefer it for its closer approximation to natural GHRH signaling.
- CJC-1295's advantage is its enhanced stability and longer duration of action, producing more robust GH elevation with less frequent dosing.
- Sermorelin benefits may suit researchers prioritizing very short-acting, physiologically similar GHRH signaling over convenience or GH elevation magnitude.